| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2024―Jul―08 |
Microbiota of upper respiratory tract in COVID-19 |
G.Sh. Isaeva, N.S. Chumarev |
| 2 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2024―Jul―08 |
Rhino-cerebral mucormycosis in patients with COVID-19: clinical cases and treatment in a regional hospital |
E.V. Dovgan, V.A. Andreev, V.N. Borovoy, E.V. Kuzmina, I.V. Andreeva, T.N. Kovalenko, et al. (+2) T.G. Ovchinnikov, O.A. Kozyrev |
| 3 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2024―Mar―14 |
Characteristics of hospitalized patients with lethal outcome due to COVID-19 |
S.K. Zyryanov, O.I. Butranova, A.A. Abramova |
| 4 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2023―May―18 |
Pulmonary aspergilloma after previous COVID-19: a case report
and a literature review |
N.V. Ovsyannikov, O.A. Bilevich, V.G. Berezhnoy, E.V. Romanovskaya, I.N. Zyatkov, O.P. Minkovich, D.I. Eshtokin |
| 5 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2023―May―18 |
COVID-19 risk factors for mortality in hospitalized patients: results
of a retrospective study |
K.A. Safonova, N.N. Dekhnich, N.D. Elistratov, E.D. Rzhevtseva, P.G. Filina, A.Yu. Kuzmenkov, et al. (+2) I.V. Trushin, A.A. Punin |
| 6 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2023―May―18 |
Patterns of antimicrobial dispensing in community pharmacies in Russia during the COVID-19 pandemic |
A.A. Kurkova, S.A. Rachina, R.S. Kozlov, U.S. Portnyagina, Sh.Kh. Palyutin, O.V. Reshetko, et al. (+5) M.V. Zhuravleva, O.Yu. Karpova, O.G. Myagkova, E.V. Kuznetsova, T.R. Kameneva |
| 7 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2023―May―18 |
Report of the Russian database on adverse drug reactions for COVID-19-related drugs with a focus on favipiravir |
S.A. Mishinova, G.I. Syraeva, A.S. Kolbin, Yu.S. Polushin, E.V. Verbickaya |
| 8 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2023―Mar―21 |
Invasive aspergillosis in patients with COVID-19 in intensive care units: results of a multicenter study |
Olga V. Shadrivova, Svetlana A. Rachina, Daria А. Strelkova, K.A. Panchishina, D.A. Gusev, M.A. Vashukova, et al. (+17) S.G. Meshchaninova, A.A. Zavrazhnov, M.S. Mitichkin, A.G. Mamonov, Sofya N. Khostelidi, O.P. Kozlova, Vitaly G. Gusarov, M.N. Zamyatin, N.V. Lovtsevich, V.G. Kuleshov, E.V. Shagdileeva, E. Oganesyan, E.A. Desyatik, Yu.V. Borzova, S.M. Ignatyeva, N.V. Vasilieva, Nikolay N. Klimko |
| 9 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Dec―29 |
Microbiological monitoring of COVID-19 patients in the ICU: a prospective observational study |
Daria А. Strelkova, Svetlana A. Rachina, V.G. Kuleshov, E.N. Burmistrova, Igor N. Sychev, N.A. Ananicheva, et al. (+2) Yu.Yu. Vasileva, E.A. Churkina |
| 10 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Dec―29 |
Corynebacterium amycolatum infective endocarditis in a patient with severe COVID-19: a case report |
Sergey S. Andreev, E.V. Ryazantseva, N.P. Maltseva, Z.Yu. Mutovina, D.S. Fomina, M.A. Lysenko |
| 11 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Dec―28 |
COVID-19 infection in hematopoietic stem cell transplant recipients |
Aleksandr A. Siniaev, A.O. Grinenko, Marina O. Popova, Yu.A. Rogacheva, A.A. Spiridonova, Yu.Yu. Vlasova, et al. (+8) A.G. Smirnova, E.V. Morozova, K.V. Lepik, N.B. Mikhailova, M.D. Vladovskaya, S.N. Bondarenko, I.S. Moiseev, A.D. Kulagin |
| 12 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Dec―28 |
Some issues of safety of antimicrobial therapy in COVID-19 patients |
Nina A. Karoli, A.P. Rebrov |
| 13 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Oct―13 |
A systematic review and meta-analysis of the safety of anti-interleukin therapy in COVID-19 |
Yu.M. Gomon, A.S. Kolbin, V.V. Strizheletsky, I.G. Ivanov, F.M. Sultanova, Yu.E. Balykina |
| 14 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Oct―13 |
Real-life antimicrobial therapy in hospitalized patients with COVID-19 (preliminary results and recommendations) |
Sergej D. Mitrokhin, O.E. Orlova, O.S. Yankovskaya, I.V. Gosteva, A.A. Galitskiy, I.V. Karpova, et al. (+2) S.G. Vedyashkina, A.S. Shkoda |
| 15 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Jan―10 |
Almost two years with COVID-19: some aspects of antibiotic use |
Eduard A. Ortenberg |
| 16 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2022―Jan―10 |
Antimicrobial resistance and antimicrobial therapy modification during COVID19 pandemic in large tertiary hospital |
O.M. Romashov, O.G. Ni, A.O. Bykov, A.N. Kruglov, D.N. Protsenko, I.N. Tyurin |
| 17 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2021―Jun―17 |
COVID19 pandemic is a «pandemic» of antimicrobial therapy |
A.I. Sinopalnikov |
| 18 |
[GO] |
Clinical Microbiology and Antimicrobial Chemotherapy |
2020―Jul―27 |
Efficacy of methylprednisolone pulse therapy in patients with COVID-19 |
Andrey A. Zaitsev, E.Z. Golukhova, M.L. Mamalyga, S.A. Chernov, M.M. Rybka, E.V. Kryukov, et al. (+3) I.V. Klyuchnikov, V.Yu. Semyonov, I.N. Orlov |
